Background
Patients with Ebstein's anomaly are at risk of tachyarrhythmia, congestive heart failure and sudden cardiac death. There are few data regarding the value of modern non-invasive diagnostic testing in prediction of outcomes. Therefore, we aimed to evaluate cardiovascular magnetic resonance (CMR) and compare it to known predictors in Ebstein's anomaly.
Methods
Seventy-nine consecutive adult patients (aged 37±15 years) with unrepaired Ebstein's anomaly underwent CMR and were followed prospectively for a mean of 3.5 ±2.6years.The major adverse cardiovascular events were defined as sustained ventricular tachycardia(VT)/heart failure hospital admission/transplantation or death. Subgroup analysis of first-onset atrial tachyarrhythmia (AT) was performed.
Results
Univariate predictors of the major adverse cardiovascular events (n=6 patients; 3 death, 3 VT) were New York Heart Association class >2 ( 
Conclusions
Ventricular functional impairment by CMR was highly predictive of mortality and VT in a large contemporary cohort of unrepaired adult patients with Ebstein's anomaly supporting the potential of CMR in risk stratification and clinical follow up. Furthermore, VT and death were preceded in almost all patients by presentation of AT suggesting that AT predicts long term adverse events early on in the disease progression. Onset of AT was best predicted by routinely measured CMR parameters feasible for clinical approach. 
